Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation

Hauser SL, Bar-Or A, Weber MS, Kletzl H, G?nther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, Koendgen H, Smith T, Kappos L. Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023 Mar; 10(2).

2023
https://researcherprofiles.org/profile/370098154
36792367

Hauser SL, Bar-Or A, Weber MS, Kletzl H, G?nther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, Koendgen H, Smith T, Kappos L